EUVIMEDEUVIMED entdecken
Open Access

Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes?

Julie Sanville iD, George A O'Toole, Juliette Madan, Modupe Coker

Journal of Pediatric Gastroenterology and Nutrition · 2024-09 · 79 (3) · 695-704

DOI: 10.1002/jpn3.12350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 09.08.2024. Verfasst von Julie Sanville und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Gastroenterology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Gastrointestinal Microbiome, Feces. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cystic Fibrosis Foundation (CFF), NIDDK NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The gut microbiota plays an important role in childhood growth. Our longitudinal cohort includes children with cystic fibrosis (CwCF) treated with highly effective modulator therapy. We aimed to elucidate early premodulator microbial signatures associated with postmodulator weight for CwCF later in childhood.

Methods

Stool samples were collected from CwCF at 13 days to 60 months. Metagenomic sequencing determined differentially abundant taxa. Children with body mass index or weight for length Z ‐scores within 1 standard deviation of the mean (SD) were considered normal weight , those >1 SD were classified as risk of overweight while children

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisGastrointestinal MicrobiomeFecesHumansFemaleMaleChild, PreschoolInfantLongitudinal StudiesInfant, NewbornOverweightBody Mass Index

Stichwörter der Autor:innen

metagenomicsmicrobial relative abundancenutrition

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Gastroenterology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Departments of Pediatrics and Psychiatry, Division of Child and Adolescent Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Department of Quantitative Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Department of Oral Biology, Rutgers School of Dental Medicine, Newark, New Jersey, USA.

ORCID-Profile: Julie Sanville

Förderung

  • Cystic Fibrosis Foundation (CFF)
  • NIDDK NIH HHS
  • National Institutes of Health (NIH)
  • NIEHS NIH HHS

Zitieren

APA

Sanville, J., O'Toole, G. A., Madan, J., & Coker, M. (2024). Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes?. Journal of Pediatric Gastroenterology and Nutrition, 79(3), 695-704. https://doi.org/10.1002/jpn3.12350

Vancouver

Sanville J, O'Toole GA, Madan J, Coker M. Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes?. Journal of Pediatric Gastroenterology and Nutrition. 2024;79(3):695-704. doi:10.1002/jpn3.12350

BibTeX
@article{Sanville2024,
  author = {Sanville, Julie and O'Toole, George A and Madan, Juliette and Coker, Modupe},
  title = {Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes?},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  volume = {79},
  number = {3},
  pages = {695--704},
  doi = {10.1002/jpn3.12350}
}
Kostenlos starten →